Chicago Partners Investment Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,265	Closed	-$38K	–	565
2021 Q4	$38K	Buy	+12,265	New	+$38K	﹤0.01%	562
2021 Q1	–	Sell	-24,870	Closed	-$139K	–	520
2020 Q4	$139K	Buy	24,870 +14,178	+133%	+$79.2K	0.01%	449
2020 Q3	$56K	Buy	+10,692	New	+$56K	0.01%	400